Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor-degenerating factor (TDF)].

Y Yamamura1, N Yamaguchi, M Hongo

  • 1Department of Microbiology, Kyoto Prefectural University of Medicine, Japan.

Human Cell
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2018 ISDE achalasia guidelines.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2018
Same author

Bradykinin system is involved in endometriosis-related pain through endothelin-1 production.

European journal of pain (London, England)·2017
Same author

Comparison of spinal alignment, muscular strength, and quality of life between women with postmenopausal osteoporosis and healthy volunteers.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.

Neurogastroenterology and motility·2017
Same author

Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Production of acetic acid by Clostridium thermoaceticum in electrodialysis culture using a fermenter equipped with an electrodialyser.

World journal of microbiology & biotechnology·2014
Same journal

The role of FOXM1 in tumor immunology: implications for cancer treatment strategies.

Human cell·2026
Same journal

Vascular reprogramming in cancer: engineering the tumor microenvironment.

Human cell·2026
Same journal

MiR-7-5p suppresses TGF-β-induced glycolysis and proliferation in intrahepatic cholangiocarcinoma by targeting MyD88.

Human cell·2026
Same journal

Bone marrow mesenchymal stem cell-derived exosomes exert therapeutic effects on inflammatory bowel disease through miR-148a-3p/Ets-1-dependent inhibition of pyroptosis.

Human cell·2026
Same journal

A model of Helicobacter infection using an artificial liver constructed by a radial-flow bioreactor.

Human cell·2026
Same journal

CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway.

Human cell·2026
See all related articles

Researchers discovered a new tumor-degenerating factor (TDF) produced by human fibroblasts that destroys human tumor cells in vitro. TDF

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Context:

  • Human tumor cells are a significant area of research.
  • Understanding the interaction between tumor cells and interstitial cells is crucial for developing new cancer therapies.

Purpose:

  • To identify and characterize a novel factor produced by human fibroblasts that exhibits tumor-degrading activity.
  • To investigate the biochemical properties and interactions of this newly discovered factor.

Summary:

  • A novel human fibroblast-producing factor, designated tumor-degenerating factor (TDF), has been identified that causes degeneration of human tumor cells in vitro.
  • TDF has an estimated molecular weight of 30 kDa, may be basic and glycosylated, and its activity is modulated by fibronectin and enhanced by interferons.
  • TDF's interaction with fibronectin inhibits its activity, while binding TDF with fibronectin also inhibits it.

Related Experiment Videos

Impact:

  • This discovery suggests TDF may play a significant role in the interplay between tumor cells and interstitial cells.
  • TDF represents a potential new therapeutic agent for cancer treatment.
  • Further research into TDF could elucidate novel mechanisms of tumor suppression and cell-cell interactions in cancer.